Mathilde Girard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mathilde Girard

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Science Immunology|November 15, 2024

A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphomaOlivier Demaria, Guillaume Habif, Marie Vetizou, et al.

Regenerative Medicine|July 13, 2016

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015David J Williams, Richard Archer, Peter Archibald, et al.

Cell Reports. Medicine|October 19, 2022

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variantOlivier Demaria, Laurent Gauthier, Marie Vetizou, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Science Immunology|November 15, 2024

A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphomaOlivier Demaria, Guillaume Habif, Marie Vetizou, et al.

Regenerative Medicine|July 13, 2016

Cell Reports. Medicine|October 19, 2022

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variantOlivier Demaria, Laurent Gauthier, Marie Vetizou, et al.

Pageof 3